HMB is used in several nutritional supplement shakes and formulas such as Ensure® aimed at decreasing muscle loss. HMB’s mechanism of action may be linked to its effect on inflammatory pathways. An increase in the ubiquitin-proteosome pathway stimulates muscle degradation that is unresponsive to nutritional interventions, and thus, must be addressed through supplementation of compounds that can directly slow the pathway. Increased NF-κβ is believed to stimulate the ubiquitin-proteosome pathway. There is also evidence that increased cytokines – especially TNF-α and IL-6 – stimulates the pathway and leads to muscle degradation(1).
HMB’s ability to down-regulate NF-κβ activation indicate a mechanistic rationale behind its ability to reduce muscle wasting. HMB has also been shown to reduce TNF-α, another cytokine indicated in ubiquitin-proteosome pathway muscle wasting. By down-regulating these factors, we can see that HMB supplementation reduces byproducts of muscle cell breaking, especially creatine kinase and lactate dehydrogenase – two enzymes found at high levels in muscle cells and during times of muscle damage, at high levels in the blood.
MSM’s effects on both NF-κβ and TNF-α are similar to those of HMB. The downstream byproducts of creatine kinase and lactate dehydrogenase seem similar as well.
One study of HMB on tumor-induced rats showed a 17% decrease in NF-κβ activation(2). A study of the effects of MSM on murine macrophages showed a decrease in NF-κβ, although it was not quantified(3). Although one study was live rats and the other in vitro, both stimulated inflammation of some form. The HMB study used tumors and the MSM study used lipopolysaccharides. In a study on human chondrocyte cells, MSM was shown to reduce the NF-κβ activation by 30%(4).
Two studies have assessed HMB’s effect on TNF-α. A post exercise study found that HMB likely decreased TNF-α levels immediately after exercise compared to placebo, but the results were not conclusive(5). An in vitro study on mononuclear cells found that HMB significantly reduced the levels of TNF-α(6). In an in vitro study on human chondrocyte cells, MSM was found to reduce the mRNA expression of TNF-α by 30%(7). An in vitro study using LPS induced murine macrophages showed that MSM at 10μg/mL significantly reduced TNF-α levels(3). And two animal studies showed that MSM reduced the levels of TNF-α in rats and mice with chemically-induced liver injuries – paraquat and carbon tetrachloride being the liver-damaging chemicals(8,9).
Creatine Kinase and Lactate Dehydrogenase
These two outcomes of muscle damage are the result of muscle cells breaking and dying. A possible reason for this damage is through inflammation – high levels of TNF-α and NF-κβ are possible culprits. Research shows the similarity between HMB and MSM. A study on HMB by and an MSM study set out similar parameters and collected similar outcomes(Barmaki et al.,2012; Knitter et al., 2013). The table below shows them side by side.
These two studies have similar exercise interventions and outcome measures. If you look specifically at the 24 hr (1day) and 48hr (2day) data points they look very similar between the two groups. These are about as similar to results as you’re likely to see between two different supplements. It would be just as likely to see this much variation in results between two studies of the same intervention. This study indicates that HMB and MSM may have similar inflammatory properties, resulting in similar downstream results.
Benefits of MSM
Although in the manner described above, HMB and MSM share very similar properties. Some differences between the two though are important and noteworthy.
IL-1, IL-6, IL-8
Several studies indicate that MSM reduces the levels of IL-1, an acute inflammatory cytokine. Three studies – two in vitro human studies and one animal study – have shown MSM significantly reducing the IL-1(Amirshahrokhi et al., 2011; Kloesch et al., 2011; Oshima et al., 2007). There are also three studies – one in vitro and two animal studies – indicating that MSM reduces the levels of IL-6(3,4,9). IL-1 and IL-6 are important acute cytokines often associated with TNF-α. IL-6, along with TNF-α, have both been suggested to be responsible for protein degradation. A study on human chondrocytes shows that MSM reduces the levels of IL-8(4), a chemokine responsible for mobilizing neutrophils. Mobilized neutrophils are suspected in causing muscle damage hours after exercise. Two HMB studies showed no improvement in IL-6 levels, one of which also showed no improvements in IL-1(Kuhls et al., 2007; Zadik et al. , 2009).
Oxidative stress is a major contributing factor in muscle damage, especially in the elderly. MSM has repeatedly shown anti-oxidative properties – in vitro studies, animal studies, and human exercise studies( Amirshahrokhi et al., 2013; Barmaki et al., 2012; Mohammadi et al., 2012; Nakhostin-Roohi et al., 2011). There is little to no information on the anti-oxidative properties of HMB. Especially in the elderly, reducing oxidative stress is paramount in reducing muscle loss.
Pain and Exercise
Most studies on the elderly digesting HMB are conducted without an exercise intervention. In the one study that combined HMB with exercise, no differences were found between HMB and placebo(Vukovich et al., 2001). Indicating that for the elderly, exercise is as beneficial as HMB in maintaining muscle. A common barrier to exercise in the elderly is muscle and joint pain. Several studies have shown MSM to be effective in alleviating joint pain, and another study indicates that MSM is effective in relieving muscle pain hours after exercise(3,18,19).
It is likely that HMB’s primary mechanism of action in reducing muscle loss centers around its effects on the ubiquitin-proteosome pathway through NF-κβ and TNF-α reduction. This leads to less muscle cell damage and helps maintain muscle mass. MSM has similar effects on NF-κβ and TNF-α, and the downstream outcomes produced by these effects, creatine kinase, and lactate dehydrogenase, are very similar to those of HMB. Where MSM is of added benefit, is its effects on IL-1, IL-6, and IL-8 to reduce acute inflammation, its anti-oxidative properties, and its ability to reduce both joint and muscle pain.
1. Tisdale MJ. Therapeutic Target for Muscle Wasting. 2005;209–17.
2. Nunes EA, Kuczera D, Brito GAP, Bonatto SJR, Yamazaki RK, Tanhoffer RA, et al. Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression. Nutr. Res. [Internet]. 2008 Jul [cited 2013 Oct 18];28(7):487–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19083450
3. Kim YH, Kim DH, Lim H, Baek D-Y, Shin H-K, Kim J-K. The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biol. Pharm. Bull. [Internet]. 2009 Apr;32(4):651–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19336900
4. Kloesch B, Liszt M, Broell J, Steiner G. Dimethyl sulphoxide and dimethyl sulphone are potent inhibitors of IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2. Life Sci. [Internet]. Elsevier Inc.; 2011 Sep 26 [cited 2013 Oct 25];89(13-14):473–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21821055
5. JR T. Beta-hydroxy-beta-methylbutyrate (HMB)-free acid attenuates circulating TNF-α and TNFR1 expression postresistance exercise . J. Appl Physiol. 1985;115(8):1173–82.
6. Nunes E a, Lomax AR, Noakes PS, Miles E a, Fernandes LC, Calder PC. β-Hydroxy-β-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitro. Nutrition [Internet]. Elsevier Ltd; 2011 Jan [cited 2013 Oct 27];27(1):92–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20541366
7. Oshima Y, Theodosakis J AD. The Effect Of Distilled Methylsulfonylmethane (MSM) on Human Chondrocytes in vitro. Osteoarthr. Cartil. 2007;15:213.
8. Amirshahrokhi K, Bohlooli S. Effect of methylsulfonylmethane on paraquat-induced acute lung and liver injury in mice. Inflammation [Internet]. 2013 Oct [cited 2013 Oct 27];36(5):1111–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23595869
9. Kamel R, El Morsy EM. Hepatoprotective effect of methylsulfonylmethane against carbon tetrachloride-induced acute liver injury in rats. Arch. Pharm. Res. [Internet]. 2013 Sep [cited 2013 Oct 27];36(9):1140–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23591777
10. Knitter AE, Panton L, Rathmacher JA, Petersen A, Sharp R, Knitter AE, et al. Effects of β -hydroxy- β -methylbutyrate on muscle damage after a prolonged run Effects of ␤ -hydroxy- ␤ -methylbutyrate on muscle damage after a prolonged run. 2013;1340–4.
11. Barmaki, S. Bohlooli, S. Khoshkhahesh, F. Nakhostin-Roohi B. Effect of methylsulfonylmethane supplementation on exercise-induced muscle damage and total antioxidant capacity. J Sport. Med Phys Fit. 2012;52:170–4.
12. Amirshahrokhi K, Bohlooli S, Chinifroush MM. The effect of methylsulfonylmethane on the experimental colitis in the rat. Toxicol. Appl. Pharmacol. [Internet]. Elsevier B.V.; 2011 Jun 15 [cited 2013 Oct 27];253(3):197–202. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21463646
13. Zadik Z, Nemet D, Eliakim A. Hormonal and metabolic effects of nutrition in athletes. J. Pediatr. Endocrinol. Metab. [Internet]. 2009 Sep;22(9):769–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19960886
14. Kuhls D a, Rathmacher J a, Musngi MD, Frisch D a, Nielson J, Barber A, et al. Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. J. Trauma [Internet]. 2007 Jan;62(1):125–31; discussion 131–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17215743
15. Nakhostin-Roohi B, Barmaki S, Khoshkhahesh F, Bohlooli S. Effect of chronic supplementation with methylsulfonylmethane on oxidative stress following acute exercise in untrained healthy men. J. Pharm. Pharmacol. [Internet]. 2011 Oct [cited 2013 Oct 27];63(10):1290–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21899544
16. Mohammadi S, Najafi M, Hamzeiy H, Maleki-Dizaji N, Pezeshkian M, Sadeghi-Bazargani H, et al. Protective effects of methylsulfonylmethane on hemodynamics and oxidative stress in monocrotaline-induced pulmonary hypertensive rats. Adv. Pharmacol. Sci. [Internet]. 2012 Jan [cited 2013 Oct 27];2012:507278. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3478703&tool=pmcentrez&rendertype=abstract
17. Vukovich MD, Stubbs NB, Bohlken RM. Body Composition in 70-Year-Old Similarly to That of Young Adults 1. J Nutr. 2001;131:2049–52.
18. Debbi EM, Agar G, Fichman G, Ziv YB, Kardosh R, Halperin N, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement. Altern. Med. [Internet]. BioMed Central Ltd; 2011 Jan [cited 2013 Oct 27];11(1):50. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3141601&tool=pmcentrez&rendertype=abstract
19. Kalman DS. A Randomized Double Blind Placebo Controlled Evaluation of MSM for Exercise Induced Discomfort/Pain. Exp. Biol. Conf. Expo. 2013.